Friday 23 August 2013

NHS Pharma-Based Service Is Brilliant, Say Pharma Shills

You know that study - widely reported on the BBC the other day, and propagandised by Nick Triggle - about how hugely successful the NHS stop smoking service is?

Well, here is the source document.

There were four authors. Robert West (RW), Sylvia May, Matthew West (MW), Emma Croghan (EC) and Andy McEwen (AMcE). Scroll down the linked page and check out the conflicts of interest.
RW is a director of the NCSCT, undertakes research and consultancy for companies that develop and manufacture smoking cessation medications (Pfizer, Johnson &Johnson, McNeil, GlaxoSmithKline, Nabi, Novartis, and Sanofi-Aventis), has a share of a patent for a novel nicotine delivery device, and is a trustee of QUIT, a charity that provides stop smoking support;
MW has a share of a patent for a novel nicotine delivery device.
EC previously worked at the English Department of Health as the delivery lead for tobacco control policy, has received travel funding, honorariums, and consultancy payments from manufacturers of smoking cessation products (Pfizer, Johnson &Johnson, McNeil, GlaxoSmithKline, Novartis, and Sanofi-Aventis), and receives royalties from a book on smoking cessation and a book on health promotion.
AMcE is a director of the NCSCT, has received travel funding, honorariums, and consultancy payments from manufacturers of smoking cessation products (Pfizer, GlaxoSmithKline, and Novartis), receives payment for providing training to smoking cessation specialists, receives royalties from books on smoking cessation, and has a share in a patent of a nicotine delivery device; no other relationships or activities that could appear to have influenced the submitted work.
This is what the BBC considers impartial headline material. Right to reply will, then, naturally be offered to Allen Carr, ECITA and the tobacco industry very soon. Yes?

Well past time that the licence fee was scrapped, doncha think?

H/T GB via FB


No comments: